Based in Hong Kong with more than 200 employees, Insilico Medicine develops an AI platform for drug development to treat cancer and age-related diseases.Alex Zhavoronkov is its founder and CEO. (Prosperity7 is the diversified growth fund of Aramco Ventures, a subsidiary of Aramco, the Saudi energy and chemicals company, with $1 billion venture capital fund and a global investment strategy in all sectors). More details about the deal here.
Prosperity7 Ventures is listed in the Middle East Investors Directory with the code BJ96.
Go to Publisher: DubaiBeat